Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Wall Street
Price Targets
Price Targets Summary
Dongkook Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.
Operating Income
Forecast
Operating Income Estimate
Dongkook Pharmaceutical Co Ltd
For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 16%.
Net Income
Forecast
Net Income Estimate
Dongkook Pharmaceutical Co Ltd
For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 15%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Dongkook Pharmaceutical Co Ltd's stock price target?
Price Target
26 010
KRW
According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.
What is Dongkook Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%
For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 10%.
What is Dongkook Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
16%
For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 16%.
What is Dongkook Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
15%
For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 15%.